Search
01/09/2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
Rodriguez-Vida, A, Valderrama, BP, Castellano, D, Pinto, A, Mellado, B, Puente, J, Climent, MA, Domenech, M, Vazquez, F, Perez-Gracia, JL, Bonfill, T, Morales-Barrera, R, Gonzalez-Billalabeitia, E, Garcia-del-Muro, X, Maroto, P, Navarro-Gorro, N, Juanpere, N, Juan, O, Bellmunt, J. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study. ESMO Open. 2024; 9(9)DOI:10.1016/j.esmoop.2024.103690. PMID:39214051. IF:8.300(Q1/2D).
01/09/2024
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
Barba, A, López-Vilaró, L, Ferre, M, Majem, M, Martinez-Recio, S, Bell, O, Arranz, MJ, Salazar, J, Sullivan, I. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. Pharmaceutics. 2024; 16(9)DOI:10.3390/pharmaceutics16091121. PMID:39339159. IF:5.500(Q1/1D).
01/09/2024
Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series
Prat, A, Piñol, D, Espadaler, I, Campazas, I, Espinosa, I, Fusté, V, Szafranska, J, Fumagalli, C. Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).
01/09/2024
NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series
Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).